NVNO vs. NSPR, VANI, MBOT, ANGO, UTMD, NPCE, RCEL, TLSI, DCTH, and OBIO
Should you be buying enVVeno Medical stock or one of its competitors? The main competitors of enVVeno Medical include InspireMD (NSPR), Vivani Medical (VANI), Microbot Medical (MBOT), AngioDynamics (ANGO), Utah Medical Products (UTMD), NeuroPace (NPCE), AVITA Medical (RCEL), TriSalus Life Sciences (TLSI), Delcath Systems (DCTH), and Orchestra BioMed (OBIO). These companies are all part of the "medical" sector.
enVVeno Medical (NASDAQ:NVNO) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their community ranking, dividends, earnings, valuation, institutional ownership, risk, analyst recommendations, media sentiment and profitability.
In the previous week, InspireMD had 1 more articles in the media than enVVeno Medical. MarketBeat recorded 2 mentions for InspireMD and 1 mentions for enVVeno Medical. enVVeno Medical's average media sentiment score of 1.87 beat InspireMD's score of 0.00 indicating that enVVeno Medical is being referred to more favorably in the media.
enVVeno Medical received 154 more outperform votes than InspireMD when rated by MarketBeat users. Likewise, 62.65% of users gave enVVeno Medical an outperform vote while only 3.70% of users gave InspireMD an outperform vote.
InspireMD has a consensus target price of $4.85, indicating a potential upside of 76.36%. Given InspireMD's higher possible upside, analysts plainly believe InspireMD is more favorable than enVVeno Medical.
34.7% of enVVeno Medical shares are held by institutional investors. Comparatively, 44.8% of InspireMD shares are held by institutional investors. 17.0% of enVVeno Medical shares are held by company insiders. Comparatively, 29.7% of InspireMD shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
enVVeno Medical has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500. Comparatively, InspireMD has a beta of 0.92, indicating that its stock price is 8% less volatile than the S&P 500.
enVVeno Medical has a net margin of 0.00% compared to InspireMD's net margin of -350.35%. InspireMD's return on equity of -55.12% beat enVVeno Medical's return on equity.
InspireMD has higher revenue and earnings than enVVeno Medical. InspireMD is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks.
Summary
InspireMD beats enVVeno Medical on 10 of the 16 factors compared between the two stocks.
Get enVVeno Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for NVNO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NVNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
enVVeno Medical Competitors List
Related Companies and Tools
